Skip to main content
. 2019 Jan 22;10(7):717–731. doi: 10.18632/oncotarget.26588

Figure 2. CXCR4 expression level (217028_at) in BAGS-defined CC and CB subtypes, for GCB-DLBCL patients.

Figure 2

Individual analysis of the LLMPP (A) CHOP treated cohort (GCB-CC, n=33; GCB-CB, n=26) and (B) R-CHOP treated cohort (GCB-CC, n=58; GCB-CB, n=25) using Welsch’s t-test to test for statistical significance, presenting mean differences with 95% CIs.